Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 3, 1991 - Issue 1
20
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Progressive Pulmonary Pathology of Two Organofluorine Compounds in Rats

, , &
Pages 123-137 | Published online: 27 Sep 2008
 

Abstract

Rat lungs were studied by light and electron microscopy to morphologically characterize the development of lung injury associated with the inhalation of two organo-fluorine compounds, perfluoroisobutylene (PFIB) and bis(trifluoromethyl) disulfide (TFD). Rats were exposed to test compounds in an inhalation chamber and euthanatized at 5 min, 30 min, 90 min, 4 h, 12 h, 24 h, and 72 h postexposure. Inhalation of the compounds resulted in a progressive pulmonary pathology dominated by pulmonary edema and fibrin deposition, which peaked at 12 to 24 h but which resolved to a large extent by 72 h postexposure. The edema was microscopically evident as early as 5–30 min after exposure. Endothelial change was the earliest recognized lesion by electron microscopy and was produced by both compounds. This was characterized by increased pinocytotic-vesicular activity and increased electron density of endothelial cells. Injury to type I and II pneumocytes was also evident, but appeared more severe in the lungs of TFD-exposed rats. The morphologic pathogenesis of the edema appears related to the primary endothelial changes and Concomitant pneumocyte damage.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.